Omacor and Placebo in Carotid Plaque Stability

• Status: Completed
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the effect of intake of Omacor (Omega-3-acid ethyl ester 90) 2g/day on specified parameters related to the stability of carotid plaque in patients awaiting endarterectomy.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pronova BioPharma

Criteria

Inclusion Criteria:

• Males of females above 18 years of age

• Patients awaiting carotid endarterectomy

• Written Informed Consent

Exclusion Criteria:

• Patients consuming fish oil or evening primrose oil preparations

• Patients eating > 2 oily fish meals per week

• Patients requiring operation within 7 days

• Pregnant or breastfeeding

• Patients participating in other clinical studies involving treatment with drug